Advertisement
Advances in Brief

Survivin-ΔEx3 and Survivin-2B: Two Novel Splice Variants of the Apoptosis Inhibitor Survivin with Different Antiapoptotic Properties

Csaba Mahotka, Michael Wenzel, Erik Springer, Helmut E. Gabbert and Claus D. Gerharz
DOI:  Published December 1999

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to March 2021

AbstractFull-text HTMLPDF
Total264382695938

Cited By

Article Information

Volume 59, Issue 24, pp. 6097-6102

PubMed 
10626797
Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received May 12, 1999
  • Accepted October 29, 1999
  • Published first December 1, 1999.
Copyright & Usage 
©1999 American Association for Cancer Research.

Author Information

  1. Csaba Mahotka,
  2. Michael Wenzel,
  3. Erik Springer,
  4. Helmut E. Gabbert, and
  5. Claus D. Gerharz2
  1. Institute of Pathology, Heinrich Heine University, D-40225 Duesseldorf, Germany
View Full Text
Back to top
December 1999
Volume 59, Issue 24

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Survivin-ΔEx3 and Survivin-2B: Two Novel Splice Variants of the Apoptosis Inhibitor Survivin with Different Antiapoptotic Properties
Csaba Mahotka, Michael Wenzel, Erik Springer, Helmut E. Gabbert and Claus D. Gerharz
Cancer Res December 15 1999 (59) (24) 6097-6102;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement